Siga Technologies (SIGA) Depreciation & Amortization (CF) (2010 - 2025)
Siga Technologies' (SIGA) quarterly Depreciation & Amortization (CF) came in at $116089.0 in Q3 2025, up 7.8% YoY from $107692.0 in Q3 2024, and down 29.51% on a QoQ basis from $164692.0 in Q2 2025.
Siga Technologies (SIGA) Depreciation & Amortization (CF) (2010 - 2025) Analysis & Trends
Siga Technologies (SIGA) has 16 years of Depreciation & Amortization (CF) data on file, last reported at $116089.0 in Q3 2025.
- Quarterly Depreciation & Amortization (CF) rose 7.8% year-over-year to $116089.0 in Q3 2025, while the trailing twelve-month figure through Dec 2025 was $416089.0 (down 22.72% YoY) and the FY2024 annual result came in at $538421.0, changed 0.02% from the prior year.
- Depreciation & Amortization (CF) fell to $116089.0 in Q3 2025, from $164692.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $172474.0 in Q2 2022 to a low of $100000.0 in Q3 2021.
- A 5-year average of $133306.0 and a median of $130826.0 in 2021 frame the typical range for Depreciation & Amortization (CF).
- Annual changes were most pronounced in 2021 — Depreciation & Amortization (CF) declined 5.74% — and 2023, when it increased 16.96%.
- Tracing SIGA's Depreciation & Amortization (CF) over 5 years: stood at $122368.0 in 2021, then decreased by 3.86% to $117643.0 in 2022, then advanced by 16.96% to $137591.0 in 2023, then decreased by 4.99% to $130729.0 in 2024, then slipped by 11.2% to $116089.0 in 2025.
- The last three Depreciation & Amortization (CF) figures came in at $116089.0 (Q3 2025), $164692.0 (Q2 2025), and $135308.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 241.00 Mn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | 119.00 Mn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | 1.02 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 24.20 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | 672.30 Mn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 171.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | Siga Technologies | 213.02 Mn | 58.06 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 116,089.00 |
| Sep 30, 2025 | 116,089.00 |
| Jun 30, 2025 | 164,692.00 |
| Jun 30, 2025 | 164,692.00 |
| Mar 31, 2025 | 135,308.00 |
| Mar 31, 2025 | 135,308.00 |
| Dec 31, 2024 | 130,729.00 |
| Dec 31, 2024 | 130,729.00 |
| Sep 30, 2024 | 107,692.00 |
| Sep 30, 2024 | 107,692.00 |
| Jun 30, 2024 | 161,529.00 |
| Jun 30, 2024 | 161,529.00 |
| Mar 31, 2024 | 138,471.00 |
| Mar 31, 2024 | 138,471.00 |
| Dec 31, 2023 | 137,591.00 |
| Dec 31, 2023 | 137,591.00 |
| Sep 30, 2023 | 100,702.00 |
| Sep 30, 2023 | 100,702.00 |
| Jun 30, 2023 | 168,879.00 |
| Jun 30, 2023 | 168,879.00 |